FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2400601392> ?p ?o ?g. }

• W2400601392 endingPage "4628" @default.
• W2400601392 startingPage "4618" @default.
• W2400601392 abstract "Attempts to maintain or expand primitive hematopoietic stem cells in vitro without the concomitant loss of their differentiative and proliferative potential in vivo have largely been unsuccessful. To investigate this problem, we compared the ability of three cloned bone marrow (BM) stromal cell lines to support the growth of primitive Thy- 1lo Sca-1+H-2Khi cells isolated by fluorescence-activated cell sorting from the BM of Ly-5.2 mice treated 1 day previously with 5-fluo- rouracil. Sorted cells were highly enriched in cobblestone area-forming cells (CAFC), but their frequency was dependent on the stromal cell lines used in this assay (1 per 45 cells on SyS-1; 1 per 97 cells on PA6). In the presence of recombinant leukemia inhibitory factor (LIF), CAFC cloning efficiency was increased to 1 per 8 cells on SyS-1 and 1 per 11 cells on PA6, thus showing the high clonogenicity of this primitive stem cell population. More primitive stem cells with competitive repopulating potential were measured by injecting the sorted cells into lethally irradiated Ly-5.1 mice together with 10(5) radioprotective Ly-5.1 BM cells whose long-term repopulating ability has been “compromised” by two previous cycles of marrow transplantation and regeneration. Donor-derived lymphocytes and granulocytes were detected in 66% of animals injected with 50 sorted cells. To quantitate the maintenance of competitive repopulating units (CRU) by stromal cells, sorted cells were transplanted at limiting dilution before and after being cultured for 2 weeks on adherent layers of SyS-1, PA6, or S17 cells. CRU represented 1 per 55 freshly sorted cells. CRU could be recovered from cocultures supported by all three stromal cell lines, but their numbers were approximately-sevenfold less than on day 0. In contrast, the addition of LIF to stromal cultures improved CRU survival by 2.5-fold on S17 and PA6 cells (approximately two-fold to threefold decline), and enabled their maintenance on SyS-1. LIF appeared to act indirectly, because alone it did not support the proliferation of Thy- 1lo Sca-1+H-2Khi cells in stroma-free cultures. Polymerase chain reaction (RT-PCR) analysis revealed that Interleukin-1beta (IL-1 beta) IL-2, IL-6, granulocyte-colony stimulating factor, granulocyte macrophage-colony stimulating factor, transforming growth factors, LIF, and Steel Factor (SLF) mRNAs were upregulated in SyS-1 within 1 to 6 hours of LIF-stimulation. To determine if increased expression of SLF by LIF-stimulated SyS-1 cells could account for their capacity to support stem cells, sorted calls were cocultured on simian CV-E cells that were transfected with an expression vector encoding membrane-bound SLF, or supplemented with soluble SLF. In both cases, SLF synergized with IL-6 produced endogenously by CV-E cells enabling CAFC growth equivalent to that on LIF-stimulated SyS-1. CAFC development on LIF- stimulated SyS-1 could also be completely abrogated by an anti-SLF antibody. These data provide evidence for a role of LIF in the support of long-term repopulating stem cells by indirectly promoting cytokine expression by BM stroma. Furthermore, we have used quantitative assays to show a maintenance of CRU numbers, with retention of in vivo function following ex vivo culture." @default.
• W2400601392 created "2016-06-24" @default.
• W2400601392 creator A5006372952 @default.
• W2400601392 creator A5018660819 @default.
• W2400601392 creator A5027849001 @default.
• W2400601392 creator A5048743123 @default.
• W2400601392 creator A5058870160 @default.
• W2400601392 creator A5063519553 @default.
• W2400601392 creator A5068044946 @default.
• W2400601392 creator A5069967565 @default.
• W2400601392 creator A5085710146 @default.
• W2400601392 date "1996-06-01" @default.
• W2400601392 modified "2023-09-28" @default.
• W2400601392 title "Leukemia inhibitory factor upregulates cytokine expression by a murine stromal cell line enabling the maintenance of highly enriched competitive repopulating stem cells" @default.
• W2400601392 cites W128311401 @default.
• W2400601392 cites W129232635 @default.
• W2400601392 cites W1487306649 @default.
• W2400601392 cites W1514172032 @default.
• W2400601392 cites W1517940049 @default.
• W2400601392 cites W1530645450 @default.
• W2400601392 cites W1578610977 @default.
• W2400601392 cites W1580591725 @default.
• W2400601392 cites W1584828020 @default.
• W2400601392 cites W1602106002 @default.
• W2400601392 cites W165253852 @default.
• W2400601392 cites W1766643663 @default.
• W2400601392 cites W183596108 @default.
• W2400601392 cites W1962521045 @default.
• W2400601392 cites W1965405390 @default.
• W2400601392 cites W1966144382 @default.
• W2400601392 cites W1973035870 @default.
• W2400601392 cites W1981892481 @default.
• W2400601392 cites W1990786859 @default.
• W2400601392 cites W1997538514 @default.
• W2400601392 cites W2006536230 @default.
• W2400601392 cites W2009328113 @default.
• W2400601392 cites W2016191371 @default.
• W2400601392 cites W2021312689 @default.
• W2400601392 cites W2074242250 @default.
• W2400601392 cites W2083459784 @default.
• W2400601392 cites W2085326817 @default.
• W2400601392 cites W2086793358 @default.
• W2400601392 cites W2090529961 @default.
• W2400601392 cites W2091386455 @default.
• W2400601392 cites W2097857054 @default.
• W2400601392 cites W2111759041 @default.
• W2400601392 cites W2149886995 @default.
• W2400601392 cites W2150951349 @default.
• W2400601392 cites W2158800860 @default.
• W2400601392 cites W2167234515 @default.
• W2400601392 cites W2262683914 @default.
• W2400601392 cites W2266106978 @default.
• W2400601392 cites W2272909649 @default.
• W2400601392 cites W2306011669 @default.
• W2400601392 cites W2336909995 @default.
• W2400601392 cites W2344986489 @default.
• W2400601392 cites W2396151093 @default.
• W2400601392 cites W2399395081 @default.
• W2400601392 cites W2404815493 @default.
• W2400601392 cites W2407412428 @default.
• W2400601392 cites W2409342484 @default.
• W2400601392 cites W2411547423 @default.
• W2400601392 cites W2413217421 @default.
• W2400601392 cites W2413701099 @default.
• W2400601392 cites W2415462242 @default.
• W2400601392 cites W322263802 @default.
• W2400601392 cites W331005909 @default.
• W2400601392 cites W335336991 @default.
• W2400601392 doi "https://doi.org/10.1182/blood.v87.11.4618.bloodjournal87114618" @default.
• W2400601392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8639830" @default.
• W2400601392 hasPublicationYear "1996" @default.
• W2400601392 type Work @default.
• W2400601392 sameAs 2400601392 @default.
• W2400601392 citedByCount "60" @default.
• W2400601392 countsByYear W24006013922012 @default.
• W2400601392 countsByYear W24006013922013 @default.
• W2400601392 countsByYear W24006013922014 @default.
• W2400601392 countsByYear W24006013922015 @default.
• W2400601392 countsByYear W24006013922021 @default.
• W2400601392 crossrefType "journal-article" @default.
• W2400601392 hasAuthorship W2400601392A5006372952 @default.
• W2400601392 hasAuthorship W2400601392A5018660819 @default.
• W2400601392 hasAuthorship W2400601392A5027849001 @default.
• W2400601392 hasAuthorship W2400601392A5048743123 @default.
• W2400601392 hasAuthorship W2400601392A5058870160 @default.
• W2400601392 hasAuthorship W2400601392A5063519553 @default.
• W2400601392 hasAuthorship W2400601392A5068044946 @default.
• W2400601392 hasAuthorship W2400601392A5069967565 @default.
• W2400601392 hasAuthorship W2400601392A5085710146 @default.
• W2400601392 hasBestOaLocation W24006013921 @default.
• W2400601392 hasConcept C109159458 @default.
• W2400601392 hasConcept C11988809 @default.
• W2400601392 hasConcept C153911025 @default.
• W2400601392 hasConcept C16930146 @default.
• W2400601392 hasConcept C203014093 @default.
• W2400601392 hasConcept C27284151 @default.
• W2400601392 hasConcept C2778690821 @default.
• W2400601392 hasConcept C2780007613 @default.

• next